drug
milsaperidone
Marketedupdated 5mo agoby $VNDA Vanda Pharmaceuticals Inc.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2indications
investigational
SchizophreniaMajor Depression
all catalysts(0)
nothing on the calendar yet
Trials studying milsaperidone
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 28, 2028
~1.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (63)
- May 31, 2044method-of-use (U-4434)US 12478619
- May 31, 2044method-of-use (U-4434)US 12478619
- May 31, 2044method-of-use (U-4434)US 12478619
- May 31, 2044method-of-use (U-4434)US 12478619
- May 31, 2044method-of-use (U-4434)US 12478619
- May 31, 2044method-of-use (U-4434)US 12478619
- May 31, 2044method-of-use (U-4435)US 12478619
- Dec 28, 2031method-of-use (U-4436)US 9074254
- Dec 28, 2031method-of-use (U-4437)US 9074254
- Dec 28, 2031method-of-use (U-4436)US 9074254
- Dec 28, 2031method-of-use (U-4436)US 9074254
- Dec 28, 2031method-of-use (U-4436)US 9074254
- Dec 28, 2031method-of-use (U-4436)US 9074254
- Dec 28, 2031method-of-use (U-4436)US 9074254
- Feb 10, 2031method-of-use (U-4436)US 90742564.4y
- Feb 10, 2031method-of-use (U-4436)US 90742564.4y
- Feb 10, 2031method-of-use (U-4436)US 90742564.4y
- Feb 10, 2031method-of-use (U-4437)US 90742564.4y
- Feb 10, 2031method-of-use (U-4437)US 90742564.4y
- Feb 10, 2031method-of-use (U-4437)US 90742564.4y
- Feb 10, 2031method-of-use (U-4437)US 90742564.4y
- Jan 16, 2031method-of-use (U-4437)US 90727424.3y
- Jan 16, 2031method-of-use (U-4437)US 90727424.3y
- Jan 16, 2031method-of-use (U-4437)US 90727424.3y
- Jan 16, 2031method-of-use (U-4437)US 90727424.3y
- Jan 16, 2031method-of-use (U-4437)US 90727424.3y
- Jan 16, 2031method-of-use (U-4437)US 90727424.3y
- Jan 16, 2031method-of-use (U-4437)US 90727424.3y
- Dec 17, 2030method-of-use (U-4437)US 90742554.2y
- Dec 17, 2030method-of-use (U-4436)US 90742554.2y
- Dec 17, 2030method-of-use (U-4436)US 90742554.2y
- Dec 17, 2030method-of-use (U-4436)US 90742554.2y
- Dec 17, 2030method-of-use (U-4436)US 90742554.2y
- Dec 17, 2030method-of-use (U-4436)US 90742554.2y
- Dec 17, 2030method-of-use (U-4436)US 90742554.2y
- Oct 28, 2030method-of-use (U-4437)US 89996384.1y
- Oct 28, 2030method-of-use (U-4437)US 89996384.1y
- Oct 28, 2030method-of-use (U-4437)US 89996384.1y
- Oct 28, 2030method-of-use (U-4437)US 89996384.1y
- Oct 28, 2030method-of-use (U-4437)US 89996384.1y
- Oct 28, 2030method-of-use (U-4437)US 89996384.1y
- Oct 28, 2030method-of-use (U-4437)US 89996384.1y
- Jul 24, 2030method-of-use (U-4437)US 105632593.8y
- Jul 24, 2030method-of-use (U-4437)US 105632593.8y
- Jul 24, 2030method-of-use (U-4436)US 105632593.8y
- Jul 24, 2030method-of-use (U-4436)US 105632593.8y
- Jul 24, 2030method-of-use (U-4437)US 105632593.8y
- Jul 24, 2030method-of-use (U-4437)US 105632593.8y
- Jul 24, 2030method-of-use (U-4437)US 105632593.8y
- Apr 5, 2030method-of-use (U-4436)US 91571213.5y
- Apr 5, 2030method-of-use (U-4437)US 91571213.5y
- Apr 5, 2030method-of-use (U-4436)US 91571213.5y
- Apr 5, 2030method-of-use (U-4436)US 91571213.5y
- Apr 5, 2030method-of-use (U-4436)US 91571213.5y
- Apr 5, 2030method-of-use (U-4436)US 91571213.5y
- Apr 5, 2030method-of-use (U-4436)US 91571213.5y
- Mar 28, 2028method-of-use (U-4436)US 105704531.5y
- Mar 28, 2028method-of-use (U-4436)US 105704531.5y
- Mar 28, 2028method-of-use (U-4437)US 105704531.5y
- Mar 28, 2028method-of-use (U-4436)US 105704531.5y
- Mar 28, 2028method-of-use (U-4436)US 105704531.5y
- Mar 28, 2028method-of-use (U-4436)US 105704531.5y
- Mar 28, 2028method-of-use (U-4436)US 105704531.5y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 59m ago
Found something off?
comments(0)
5-min edit window · permanent after that